Advertisement
UK markets closed
  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     
  • FTSE 250

    20,286.03
    -45.77 (-0.23%)
     
  • AIM

    764.38
    -0.09 (-0.01%)
     
  • GBP/EUR

    1.1796
    -0.0009 (-0.07%)
     
  • GBP/USD

    1.2646
    +0.0005 (+0.04%)
     
  • Bitcoin GBP

    48,701.73
    +558.45 (+1.16%)
     
  • CMC Crypto 200

    1,281.23
    -2.60 (-0.20%)
     
  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     
  • DOW

    39,118.86
    -45.24 (-0.12%)
     
  • CRUDE OIL

    81.46
    -0.28 (-0.34%)
     
  • GOLD FUTURES

    2,336.90
    +0.30 (+0.01%)
     
  • NIKKEI 225

    39,583.08
    +241.58 (+0.61%)
     
  • HANG SENG

    17,718.61
    +2.11 (+0.01%)
     
  • DAX

    18,235.45
    +24.85 (+0.14%)
     
  • CAC 40

    7,479.40
    -51.32 (-0.68%)
     

Eye Care Innovator In Buy Zone; 176% Growth Expected For IBD 50 Stock

Eye Care Innovator In Buy Zone; 176% Growth Expected For IBD 50 Stock

This cataract lens stock has gained 44% this year and over 200% since 2023. Analysts expect the company to turn profitable in 2024.